Companies: 10,795·Total market cap: $144.5T
Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc.

BLPHNASDAQHealthcare
$0.01
$-0.01(-36.84%)
Market Cap$146791
P/E Ratio
52W High$0.1
52W Low$0.01
Overview

Bellerophon Therapeutics, Inc.(BLPH)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BLPH · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.02B$0.01B$0.02B$0.01B$0.02B
G&A Expenses$0.01B$0.01B$0.01B$0.01B$0.01B
Total Operating Expenses$0.02B$0.02B$0.03B$0.02B$0.03B
Operating Income($0.02B)($0.02B)($0.03B)($0.02B)($0.03B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.02B)($0.02B)($0.03B)($0.02B)($0.00B)
Income Tax Expense($0.00B)($0.00B)($0.00B)($0.00B)($0.01B)
Net Income($0.02B)($0.02B)($0.02B)($0.01B)$0.00B
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.08$-1.87$-3.17$-2.95$0.65
Wtd Avg Shares0.01B0.01B0.01B0.00B0.00B
EBITDA($0.02B)($0.02B)($0.03B)($0.01B)($0.00B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Bellerophon Therapeutics, Inc.

关于Bellerophon Therapeutics, Inc.(BLPH)损益表

Bellerophon Therapeutics, Inc.(BLPH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,BLPH实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.02B)(净利率—)。

常见问题

BLPH · 4 问

Bellerophon Therapeutics, Inc.(BLPH)2022财年营收为$0.00B,同比down—%。

BLPH revenueBLPH salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09